Caffeine-Mediated Inhibition of Calcium Release Channel Inositol 1,4,5-Trisphosphate Receptor Subtype 3 Blocks Glioblastoma Invasion and Extends Survival

• Published in: Cancer research (Chicago, Ill.) Ill.), 2010-02, Vol.70 (3), p.1173-1183
• Main Authors: SANG SOO KANG, HAN, Kyung-Seok, SEUNG HYUN YOO, CHUN KEE CHUNG, PARK, Sung-Hye, SUN HA PAEK, EUN JOO ROH, SUNG JOONG LEE, PARK, Jae-Yong, TRAYNELIS, Stephen F, LEE, C. Justin, BO MI KU, YEON KYUNG LEE, HONG, Jinpyo, HYE YOUNG SHIN, ALMONTE, Antoine G, DONG HO WOO, BRAT, Daniel J, EUN MI HWANG
• Format: Article
• Language: English
• Subjects: Animals; Antineoplastic agents; Biological and medical sciences; Caffeine - pharmacology; Calcium - metabolism; Cell Line; Cell Line, Tumor; Cell Movement - drug effects; Cell Survival - drug effects; Central Nervous System Stimulants - pharmacology; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Glioblastoma - drug therapy; Glioblastoma - metabolism; Glioblastoma - pathology; Humans; Inositol 1,4,5-Trisphosphate Receptors - antagonists & inhibitors; Inositol 1,4,5-Trisphosphate Receptors - genetics; Inositol 1,4,5-Trisphosphate Receptors - metabolism; Medical sciences; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neurology; Oligonucleotide Array Sequence Analysis; Pharmacology. Drug treatments; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction - drug effects; Survival Analysis; Tumor Cells, Cultured; Tumors; Tumors of the nervous system. Phacomatoses; Xenograft Model Antitumor Assays
• ISSN: 0008-5472; 1538-7445
• DOI: 10.1158/0008-5472.CAN-09-2886

Calcium signaling is important in many signaling processes in cancer cell proliferation and motility including in deadly glioblastomas of the brain that aggressively invade neighboring tissue. We hypothesized that disturbing Ca(2+) signaling pathways might decrease the invasive behavior of giloblastoma, extending survival. Evaluating a panel of small-molecule modulators of Ca(2+) signaling, we identified caffeine as an inhibitor of glioblastoma cell motility. Caffeine, which is known to activate ryanodine receptors, paradoxically inhibits Ca(2+) increase by inositol 1,4,5-trisphospate receptor subtype 3 (IP(3)R3), the expression of which is increased in glioblastoma cells. Consequently, by inhibiting IP(3)R3-mediated Ca(2+) release, caffeine inhibited migration of glioblastoma cells in various in vitro assays. Consistent with these effects, caffeine greatly increased mean survival in a mouse xenograft model of glioblastoma. These findings suggest IP(3)R3 as a novel therapeutic target and identify caffeine as a possible adjunct therapy to slow invasive growth of glioblastoma.